Donald Brock
Cardiovascular Disease · West Orange, NJNPI 1659371334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 25.8% of the total. Reporting peaked in 2019 at $644 and has fallen 97.4% since, to $16 in 2024. That places this record below the midpoint for cardiovascular disease clinicians in NJ, where the typical reported total is $2,633.
Across 90 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$348
- Novartis$308
- Abbott$155
- Pfizer$122
- Lundbeck LLC$98
- Sanofi-aventis U.S. LLC$59
- plus $258 from 12 others
What the payments were for
- Food & beverage$1,33599%
- Other$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $348 |
| Novartis | 23 | $308 |
| Abbott | 5 | $155 |
| Pfizer | 9 | $122 |
| Lundbeck LLC | 7 | $98 |
| Sanofi-aventis U.S. LLC | 4 | $59 |
| Irhythm Technologies, Inc. | 1 | $47 |
| Merck | 3 | $42 |
| Medtronic | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Amarin Pharma, Inc. | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Welch Allyn | 1 | $12 |
| Vifor Pharma, Inc. | 1 | $11 |
| Althera Pharmaceuticals LLC | 1 | $11 |
How this compares
$1,347 in reported general payments places this provider in the 30th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in West Orange
- Fadi ChaabanWest Orange$161K
- Sabino TorreWest Orange$57K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.